UniProt ID | SIAH1_HUMAN | |
---|---|---|
UniProt AC | Q8IUQ4 | |
Protein Name | E3 ubiquitin-protein ligase SIAH1 | |
Gene Name | SIAH1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 282 | |
Subcellular Localization | Cytoplasm. Nucleus. Predominantly cytoplasmic. Partially nuclear. | |
Protein Description | E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Mediates E3 ubiquitin ligase activity either through direct binding to substrates or by functioning as the essential RING domain subunit of larger E3 complexes. Triggers the ubiquitin-mediated degradation of many substrates, including proteins involved in transcription regulation (ELL2, MYB, POU2AF1, PML and RBBP8), a cell surface receptor (DCC), the cell-surface receptor-type tyrosine kinase FLT3, the cytoplasmic signal transduction molecules (KLF10/TIEG1 and NUMB), an antiapoptotic protein (BAG1), a microtubule motor protein (KIF22), a protein involved in synaptic vesicle function in neurons (SYP), a structural protein (CTNNB1) and SNCAIP. Confers constitutive instability to HIPK2 through proteasomal degradation. It is thereby involved in many cellular processes such as apoptosis, tumor suppression, cell cycle, axon guidance, transcription regulation, spermatogenesis and TNF-alpha signaling. Has some overlapping function with SIAH2. Induces apoptosis in cooperation with PEG3. Upon nitric oxid (NO) generation that follows apoptotic stimulation, interacts with S-nitrosylated GAPDH, mediating the translocation of GAPDH to the nucleus. GAPDH acts as a stabilizer of SIAH1, facilitating the degradation of nuclear proteins.. | |
Protein Sequence | MSRQTATALPTGTSKCPPSQRVPALTGTTASNNDLASLFECPVCFDYVLPPILQCQSGHLVCSNCRPKLTCCPTCRGPLGSIRNLAMEKVANSVLFPCKYASSGCEITLPHTEKADHEELCEFRPYSCPCPGASCKWQGSLDAVMPHLMHQHKSITTLQGEDIVFLATDINLPGAVDWVMMQSCFGFHFMLVLEKQEKYDGHQQFFAIVQLIGTRKQAENFAYRLELNGHRRRLTWEATPRSIHEGIATAIMNSDCLVFDTSIAQLFAENGNLGINVTISMC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRQTATAL ------CCCCCCCCC | 32.85 | 18669648 | |
7 | Phosphorylation | -MSRQTATALPTGTS -CCCCCCCCCCCCCC | 31.92 | 22985185 | |
11 | Phosphorylation | QTATALPTGTSKCPP CCCCCCCCCCCCCCH | 54.67 | 22985185 | |
13 | Phosphorylation | ATALPTGTSKCPPSQ CCCCCCCCCCCCHHH | 27.73 | 18669648 | |
14 | Phosphorylation | TALPTGTSKCPPSQR CCCCCCCCCCCHHHC | 33.34 | 22985185 | |
15 | Ubiquitination | ALPTGTSKCPPSQRV CCCCCCCCCCHHHCC | 51.07 | - | |
19 | Phosphorylation | GTSKCPPSQRVPALT CCCCCCHHHCCCCCC | 18.76 | 9858595 | |
19 (in isoform 2) | Phosphorylation | - | 18.76 | - | |
33 (in isoform 2) | Phosphorylation | - | 43.08 | 18669648 | |
46 (in isoform 2) | Ubiquitination | - | 27.75 | - | |
70 | Phosphorylation | SNCRPKLTCCPTCRG CCCCCCCEECCCCCC | 20.42 | 26714015 | |
74 | Phosphorylation | PKLTCCPTCRGPLGS CCCEECCCCCCCCHH | 10.83 | - | |
89 | Acetylation | IRNLAMEKVANSVLF HHHHHHHHHHHHCCC | 33.30 | 19825753 | |
100 | Phosphorylation | SVLFPCKYASSGCEI HCCCEEECCCCCCEE | 20.59 | 16230351 | |
126 | Phosphorylation | ELCEFRPYSCPCPGA HHCCCCCCCCCCCCC | 20.74 | 16230351 | |
216 | Ubiquitination | VQLIGTRKQAENFAY HHHHCCHHHHHHHHH | 54.41 | 33845483 | |
235 | Phosphorylation | NGHRRRLTWEATPRS CCCCCCCCEECCCCC | 21.32 | - | |
239 | Phosphorylation | RRLTWEATPRSIHEG CCCCEECCCCCHHHH | 14.02 | - | |
247 | Ubiquitination | PRSIHEGIATAIMNS CCCHHHHHHHHHHCC | 2.54 | 22053931 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
19 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
19 | S | Phosphorylation | Kinase | ATR | Q13535 | Uniprot |
70 | T | Phosphorylation | Kinase | ASK1 | Q99683 | PSP |
74 | T | Phosphorylation | Kinase | ASK1 | Q99683 | PSP |
235 | T | Phosphorylation | Kinase | ASK1 | Q99683 | PSP |
239 | T | Phosphorylation | Kinase | ASK1 | Q99683 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
19 | S | Phosphorylation |
| 18536714 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SIAH1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpointkinases ATM and ATR."; Winter M., Sombroek D., Dauth I., Moehlenbrink J., Scheuermann K.,Crone J., Hofmann T.G.; Nat. Cell Biol. 10:812-824(2008). Cited for: FUNCTION, MUTAGENESIS OF SER-19 AND CYS-44, INTERACTION WITH HIPK2,AND PHOSPHORYLATION AT SER-19 BY ATM AND ATR. |